<?xml version="1.0" encoding="UTF-8"?>
<p id="Par75">A 2D echocardiogram was performed at baseline, before hospital discharge and after 6 and 12 months to evaluate LV function, volumes and wall motion score index (WMSI). Pericardial effusions and unwanted tissue changes were also assessed during the study period. Echocardiogram acquisition and analyses were performed according to the guidelines [
 <xref ref-type="bibr" rid="CR22">22</xref>]. The 2D echocardiogram at screening was also applied to assess the presence and localization of LV wall thickness &lt; 8 mm at the target sites of cell injections.
</p>
